The FDA has granted traditional approval for the use of encorafenib (Braftovi) in combination with cetuximab and fluorouracil-based chemotherapy for treatment-naïve adults with BRAF V600E–mutant metastatic...
A large randomized trial found that mailing unsolicited fecal immunochemical test kits increased colorectal cancer screening rates among adults aged 45 to 49 compared with strategies requiring patients to...
Robotic surgery significantly reduced the 3-year locoregional recurrence rate and improved disease-free survival in patients with middle or low rectal cancer compared with conventional laparoscopic surgery....
Researchers conducted a cross-sectional clinical trial with 8920 participants to evaluate whether a multitarget stool RNA test could serve as a noninvasive tool for detecting colorectal cancer, offering an...
The American College of Physicians have released an updated set of guidelines addressing when and how clinicians should screen for colorectal cancer in patients.
Previous studies have sought to determine the relationship between cancer and a vegetarian diet. In this study, the researchers examined the impact of various vegetarian and non-vegetarian diets on the risk...
Ulcerative colitis (UC) is a risk factor for colorectal cancer (CRC), but authors of a new study evaluated whether patients with UC are still at greater risk for CRC and CRC-related mortality even after the...
Researchers aimed to investigate the impact of obesity on young-onset colorectal cancer risk in more than 85,000 women from the Nurses’ Health Study II.
According to the World Cancer Research Fund and American Institute for Cancer Research, colorectal cancer is the third most common cancer worldwide. They have recently updated their joint recommendations to...
The 2016 US Preventive Services Task Force evidence report on colorectal cancer screening initially concluded that no methods of screening reduced the risk of all-cause mortality among these patients....
